Tuesday, 23 November 2021

Covaxin 50% Effective When Delta Was Dominant, Shows Lancet Study

Two doses of Covaxin are 50 per cent effective against symptomatic disease, according to the first real-world assessment of India's indigenous COVID-19 vaccine published in The Lancet Infectious...

from NDTV News - Special https://ift.tt/3xfTTwS
via

No comments:

Post a Comment

Blue Origin Targets November 22 for Next Space Tourism Flight NS-28

Jeff Bezos' aerospace venture, Blue Origin, has confirmed plans to launch its ninth crewed mission, NS-28, on Friday, November 22, 2024...